Salivary glands are essential for the maintenance of oral health by providing lubrication and antimicrobial protection to the mucosal and tooth surfaces. Saliva is modified and delivered to the oral cavity by a complex multifunctional ductal system. During development, these ducts form as solid tubes, which undergo cavitation to create lumens. Apoptosis has been suggested to play a role in this cavitation process along with changes in cell polarity. Here, we show that apoptosis occurs from the very earliest stages of mouse salivary gland development, much earlier than previously reported. Apoptotic cells were observed in the center of the first epithelial stalk at earlystage embryonic day 12.5 (E12.5) according to both TUNEL staining and cleaved caspase 3 immunofluorescence. The presumptive lumen space was highlighted by the colocalization of a predictive lumen marker, cytokeratin 7. At E14.5, as lumens start to form throughout the glands, apoptotic expression decreased while cytokeratin 7 remained positive. In vitro inhibition of all caspases in E12.5 and E13.5 salivary glands resulted in wider ducts, as compared with the controls, and a defect in lumen formation. In contrast, no such defect in lumen formation was observed at E14.5. Our data indicate that apoptosis is involved during early stages of gland formation (E12.5 onward) and appears important for shaping the forming ducts.
Introduction
During epithelial organogenesis, lumen formation within an initially solid tube is essential for building functional networks of epithelial tubes in different organs, such as mammary and salivary glands (SGs) (Mailleux et al. 2007; Kwon and Larsen 2015) . It has been postulated that canalization of SG ducts and other glands is due to clearance of the inner cell population within newly branched epithelial stalks by apoptosis, a form of programmed cell death. Lumen formation therefore occurs secondarily to branching morphogenesis (Lubarsky and Krasnow 2003; Andrew and Ewald 2010) . The role of cell death in SGs, however, has recently been challenged, with lumen formation occurring after apoptosis is blocked (Nedvetsky et al. 2014) .
As previously described, SG development is generally classified into prebud, initial bud, pseudoglandular, canalicular, and terminal bud stages, with gland initiation occurring around embryonic day 11 (E11) in the mouse (Jaskoll and Melnick 1999) . The prebud stage is characterized as a thickening of the oral epithelium, which proliferates toward the underlying mesenchyme and forms an epithelial bud with a narrow stalk region (initial bud stage). The bud then undergoes clefting to create multiple buds that characterize the pseudoglandular stage. The epithelial stalks then undergo canalization, while ductal and acinar cells then differentiate to achieve a mature gland (Jaskoll and Melnick 1999) . This pattern of development is very similar to the stages observed during human development (Lourenço et al. 2008; Teshima et al. 2011 ).
To date, lumen formation in SGs has been reported to start from E14.5 Tucker 2007 ). Apoptotic cells have been observed localized in the developing ducts, and active caspase 3, a central mediator of the apoptotic pathway, is expressed in these regions (Jaskoll and Melnick 1999; Jaskoll et al. 2001) . In keeping with an active role of apoptosis in lumen formation, Survivin-a member of the inhibitors of apoptosis protein family-is expressed in the nucleus of epithelial cells bordering the forming lumina as the canals start to form .
Programmed cell death can be triggered by different molecular pathways. The extrinsic pathway involves apoptotic signaling from outside the cell, mediated by members of the tumor necrosis factor receptor superfamily (Elmore 2007) . The intrinsic pathway depends on endogenous factors to activate apoptosis and is stimulated by intracellular stress, such as DNA damage, hypoxia, oncogene activation, and deprivation of growth factors. The mitochondria is the central organelle of this pathway and releases several proapoptotic molecules into the cytoplasm (Elmore 2007; Taylor et al. 2008) .
Given the specific functions of the SG ductal system to properly secrete and deliver saliva in the oral cavity, it is important to understand the mechanisms involved in SG formation. In other systems, cell polarization, apoptosis, anoikis, and cord hollowing have been suggested to play a role in epithelial tubulogenesis (Debnath et al. 2002; Mailleux et al. 2007; Andrew and Ewald 2010; Nedvetsky et al. 2014) . Here, we have concentrated on the role of apoptosis, analyzing the temporal expression of apoptotic markers during early SG development and using inhibition of apoptosis in culture, thereby introducing a potential early role of caspase-dependent apoptosis in lumen formation starting prior to branching morphogenesis.
Material and Methods

Organ Culture
Mouse tissue was collected from wild-type CD1 animals housed in the Biological Services Unit in New Hunts House at King's College London in approved nonspecific-pathogen-free conditions. Mice were culled via schedule 1 culling methods, as approved by the Home Office and King's College London. Animal experiments conform to ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines. Embryonic SGs at stages E12.5 to E14.5 were dissected out for cultures and immunohistochemistry analysis (n = 6 of each stage and group).
Pan-caspase inhibitor Z-VAD-FMK (G7231, Promega, Madison, WI, USA) was used for in vitro apoptotic inhibition at a range of concentrations (100, 150, 200 µM) at E13.5 and E14.5 (n = 9) and at 100 µM at E12.5 (n = 18). Samples were placed on permeable membranes (BD, Franklin Lakes, NJ, USA) over culture medium (Advanced Dulbecco Modified Eagle Medium F12, Invitrogen, Waltham, MA, USA; 1% GlutaMAX, Invitrogen; 1% penicillin-streptomycin) at 37 °C and 5% CO 2 . Controls were cultured in dimethyl sulfoxide (DMSO) at the same concentration. In situ CaspACE FITC-Z-VAD-FMK marker (G7461, Promega) was added to the culture medium in the last day for 3 h. Cultured SGs were then fixed for 30 min at room temperature and washed in phosphate-buffered saline (PBS).
LysoTracker RED (DND-99, Invitrogen) was added in culture medium (5 µM) of live SGs (n = 6 of each stage) for 3 h. After washing with fresh culture medium and PBS Triton 0.1%, samples were fixed in 4% paraformaldehyde for 30 min at room temperature. Samples were permeabilized with PBS Triton 0.1% for 15 min, followed by incubation in blocking solution for 2 h and DAPI (1:1,000; Invitrogen) for 4 h at room temperature. For immunohistochemistry/immunofluorescence and morphometric analysis, see the Appendix Methods.
Results
Previous papers have concentrated on apoptosis during duct cavitation from E14.5 onward; we therefore wanted to analyze whether apoptosis also had a role during earlier stages of gland development, when the main stalk of the gland is formed. Morphologic analysis of early stages is shown in Fig. 1 (A, E, I), and the epithelial structures of forming SGs are highlighted with E-cadherin staining ( Fig. 1B , F, J). The opening of the first lumenal space appears from E13.5 ( Fig. 1E , arrow). Specific apoptotic activity was confirmed with cleaved caspase 3 and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) at the same stages (Fig. 1C , G, K and 1D, H, L, respectively; Appendix Fig. 1 ). Both markers were found in the center of the main epithelial stalk at E12.5 where the lumen space is due to form (Fig. 1C, D) . High levels of apoptotic cells were observed at E13.5 within the main duct and the oral epithelium ( Fig. 1G , H; Appendix Fig. 1 ). Interestingly, sparse ( Fig. 1K , arrow) or no positive cells ( Fig.  1L , arrowheads) were observed in the more developed ducts at E14.5. At E12.5, subtle luminal gaps were observed within the main stalk ( Fig. 1M , arrowheads), and at E13.5 they were clear within the duct associated with dying cells (Fig. 1O , arrowheads). In contrast, the duct closer to the branching region had not yet initiated lumen formation. At these early stages, dying cells were found in the center of the main epithelial stalk via LysoTracker staining, which labels lysozymes ( Fig. 1N , P, arrows; Fogel et al. 2012 ). Colocalization of LysoTracker and cleaved caspase 3 expression was observed in the duct of the submandibular gland at E13.5 ( Fig. 1Q-T ). In the sublingual gland, which is delayed in development compared with the neighboring submandibular (Redman and Ball 1978) , cleaved caspase 3-positive cells were observed running along the forming duct, while LysoTracker was not yet expressed ( Fig.  1Q , R), confirming that presence of cleaved caspase 3 is an early indicator of lumenal space opening.
To confirm the presence of the forming lumen, cytokeratin 7 (K7) was used to identify the presumptive luminal areas within the ducts as previously reported in developing SGs (Walker et al. 2008 ) and also in less differentiated cells of the ductal tree in the mammalian pancreas (Bouwens 1998) (Fig.  2) . At E12.5, K7 expression was observed in the central cells of the epithelial stalk connected to the single bud ( Fig. 2A , arrows), while expression was completely absent in the bud itself ( Fig. 2A, arrowhead) . At E13.5, a stronger expression was observed in the luminal cells of the main duct, lining the developing gaps ( Fig. 2B, arrow) . Toward the canalization stage at E14.5, the expression of K7 remained positive in the center of the ductal structures where clear lumens were developing ( Fig. 2C , arrows). During these stages, K7 expression was also observed in the oral epithelium, with expression increasing at a later stage (E14.5; Fig. 2D , arrow).
The role of apoptosis in the main stalk was analyzed by in vitro culture to block apoptosis via a pan-caspase inhibitor at 100 µM in the developing glands. Caspases are the main effectors and activators of the intrinsic and extrinsic apoptotic pathways (Degterev et al. 2003; Taylor et al. 2008) . SG explants at E12.5 were cultured for 72 h. During this period, the wild-type cultures developed from a budlike thickening to a main bud that had started to cleft, attached to the oral epithelium by a narrow stalk. In contrast, the stalk region failed to narrow in the caspasetreated explants (Fig. 3A, arrows) . The diameter of the main primary stalk of each gland was measured in both experimental and control groups at the start and during culture, resulting in statistically significant difference from 24 h ( Fig. 3B ; P < 0.05, n = 18). E12.5 cultures developed much slower than those without DMSO, the carrier used, indicating that this early stage is sensitive to even fairly low levels of this vehicle. In agreement with this, a higher concentration of inhibitor and, therefore, carrier led to arrest of gland development (data not shown). We subsequently performed a similar functional experiment using E13.5 and E14.5 SGs to assess the effects of pancaspase inhibition on duct development at later stages. For this, we used the concentrations of 100 µM plus 150 µM and 200 µM. At E13.5, the addition of 150µM and 200µM inhibitor led to complete loss of apoptotic cells, as determined by activated caspase 3 staining, after 20 h in culture; yet at 100 µM, a few positive cells were observed, indicating that some cells had escaped inhibition at this concentration at this stage ( Fig. 4A , arrows; n = 3 each concentration). At E13.5 addition of Z-VAD-FMK inhibitor resulted in wider stalks in a dose-dependent manner ( Fig. 4B ). At 150 µM, statistically significant wider stalks were observed after 72 h in culture (Fig.  4C ). The wide morphology of the ductal structures after treatment agrees with the data from E12.5, suggesting that caspase-dependent apoptosis plays a role in the narrowing of the ducts prior to lumen formation. At E13.5, branching was also impaired showing reduction in the number of buds when cultured at higher concentrations of inhibitor ( Fig. 4D, Fig. 5A-F ). In contrast, E14.5 SG cultures showed no abnormality within all groups (Appendix Fig. 2) , agreeing with the fact that only low levels of apoptosis are evident at this stage (see Fig. 1 ).
To label cells that had been blocked by the inhibitor, plus cells that were undergoing cell death just before fixation, the apoptotic inhibitor marker FITC-Z-VAD-FMK was added to Figure 1G , J. A few positive cells were evident in the mesenchyme, increasing with higher concentration of DMSO, indicating some cell death in the mesenchyme at the end of the culture period. This again highlights the toxicity of DMSO for developing SGs and the need to be careful when analyzing results when using higher concentrations. In the inhibitor-treated cultures, large numbers of positive cells were concentrated at the center of the main ducts, corresponding to the pattern of apoptosis observed in glands in vitro at the start of culture (Fig. 5B′ , D′, F′ compared with Fig. 1 ). In addition to the effect on width of the duct, lumen formation appeared abnormal. In the controls at 100 µM and 150 µM, clear, cell-free lumens formed in the central stalk ( Fig.  5A, A′, B, B′) . In contrast, this region in the caspase inhibitor cultures was filled with fluorescein isothiocyanate (FITC) labeled cells (Fig. 5D ). In section, the lack of lumen was clear in the inhibitor-treated cultures (Appendix Fig. 1 ). In addition to defects in duct morphogenesis, E13.5 samples showed a dose-dependent defect in branching morphogenesis (Fig. 5) . The reduced branching was not expected, as very few apoptotic cells were associated with this part of the gland at these stages; however, the FITC marker also showed high levels of inhibitor binding in the mesenchyme, particularly at high concentrations (Fig. 5D′, F′) , suggesting that the inhibitor may also have had an impact on normal development of the mesenchyme, therefore indirectly affecting branching morphogenesis.
Discussion
Apoptosis has been recognized as one of the most important mechanisms involved in developmental dynamics (Flusberg and Sorger 2015) with the large caspases being key regulators of the main programmed cell death pathways (Hengartner 2000; Degterev et al. 2003; Taylor et al. 2008; Kuranaga 2011) . Branching morphogenesis regulates the formation of distinct organs such as lungs, kidney, and mammary and salivary glands, which can perform essential physiologic functions, such as exchanging gases or production of secretions (Patel et al. 2006; Larsen et al. 2010; Ochoa-Espinosa and Affolter 2012; Patel and Hoffman 2014) . Studies on epithelial tube morphogenesis have highlighted the involvement of distinct methods for lumen formation depending on the type of organ involved (Lubarsky and Krasnow 2003; Chung and Andrew 2008; Andrew and Ewald 2010) . In SGs, it has been suggested that the central cells of the epithelial stalks undergo apoptosis in a process known as cavitation, clearing the luminal space during embryonic SG development (Tucker 2007 ; Wells and Patel 2010). Corroborating these previous reports, our findings illustrate the presence of dying cells in the center of the presumptive ducts, as shown by LysoTracker staining, activated caspase 3, and TUNEL. Temporal expression of apoptotic cells in duct formation, however, diverged from previous studies. To date, it has been reported that mouse SG lumen spaces start opening only from stage E14.5 or E15.5, with apoptotic cells and cleaved caspase 3 observed from E14.5 (Jaskoll and Melnick 1999; Melnick et al. 2001) . It is therefore assumed that SGs are composed of solid and nonluminized cords before this time point Larsen et al. 2006; Tucker 2007) . In this study, apoptotic cells were detected at earlier stages, from E12.5, suggesting an important early role for apoptosis in the formation of the lumen of the central SG ducts; the central duct was also shown to open at early stages of development, before the rest of the gland had undergone branching morphogenesis. This finding was further supported by the expression of K7 in the center of the main stalk of developing SGs from E12.5 (Walker et al. 2008) . Such discrepancy could be due to the fact that earlier stages were not studied in details or that different methods for detecting apoptosis were employed. Jaskoll and Melnick (1999) reported the presence of apoptotic cells only from E14.5 using the Apostain assay, which identifies DNA after caspase cleavage and before DNA fragmentation. Comparison between TUNEL and Apostain assays have reported good reliability of both techniques, although their outcomes showed slight variations in the timing and amount of expression (Prochazkova et al. 2003) .
Our results revealed scarce/occasional apoptotic cells (cleaved caspase 3 and TUNEL positives) at later stages, E14.5 and E15.5, and no overt defect in gland development in cultures treated with inhibitor from E14.5, indicating a more minor role for apoptosis at these later time points. Functional experiments were performed to assess the effects of suppressing apoptotic activity in SG development through in vitro pan-caspase inhibition. The Z-VAD-FMK inhibitor binds irreversibly to active caspases, and from the lowest concentration of 100 µM it was able to compromise SG development at early stages. In previous studies using epithelial cell cultures, apoptotic inhibition was sufficient to avoid lumen formation when cell polarization was not enhanced (Martín-Belmonte et al. 2008) . However, when cell polarization was stimulated in prostate epithelial models, inhibition of apoptosis only delayed lumen formation (Pearson et al. 2009 ). Studies with mammary cell cultures have also shown similar results by inhibiting apoptosis, correlating apoptosis with generation and maintenance of hollow lumen spaces (Debnath et al. 2002) .
Defects in branching and duct formation due to pan-caspase inhibition reveal an important function of apoptosis during SG development. However, it is worth bearing in mind that caspase inhibition can trigger the activation of non-caspase-dependent cell death pathways, such as necrosis and autophagy, which could compensate for the absence of apoptosis (Vandenabeele et al. 2006) . Additionally, it has been reported that caspase functions are not exclusively apoptotic, being also correlated to dynamic cell processes such as cell fate determination, compensatory proliferation of neighboring cells, and actin cytoskeleton reorganization, in a nonapoptotic context during mouse development (Wang and Lenardo 2000; Kuranaga 2011) . Caspase inhibition can therefore potentially affect other essential mechanisms during embryogenesis, which might have resulted in the severe phenotypes observed in our in vitro cultures not only in duct formation but also in epithelial branching. The importance of apoptosis during organ development was recently correlated to effects on proliferation, movement, and shape of neighboring cells (Pérez-Garijo and Steller 2015), suggesting an additional function for those apoptotic cells during early SG development.
Studies analyzing epithelial cell interactions during SG development have shown links between control of lumen formation and cell polarization (Cutler and Mooradian 1987; Andrew and Ewald 2010) , supported more recently by genetic links between the 2 processes (Nedvetsky et al. 2014) . Neuronalderived vasoactive intestinal peptide (VIP) was found as an important regulator of key steps during epithelial tubulogenesis in SG development, where exogenous VIP stimulated the formation of a single contiguous lumen space, as marked by apical atypical protein kinase C (aPKC) and subapical GM130, from E13. Moreover, it was reported that VIP-induced lumen formation did not require apoptosis, showing normal lumen formation in SGs cultured with pan-caspase inhibitor. In this experiment, the inhibitor was used at 50 µM, whereas we saw only partial inhibition using a higher concentration of 100 µM; as such, the lack of phenotype in the Nedvetsky paper could therefore be due to the low dose of Z-VAD-FMK used. Normal lumens were also observed in Bax-knockout mice; however, they were analyzed only at E17. In this case, it is possible that Bax-dependent lumen formation was compensated for by other cell death mechanisms or analogous molecules. This protein is required only for intrinsic apoptosis, and it shares similar proapoptotic function with another apoptotic protein, Bak (Lindsten et al. 2000; Karbowski et al. 2006) . Compensation by other cell death pathways is a common mechanism observed in other areas where cell death has been investigated, for example, in the limb (Miura 2012; Suzanne and Steller 2013) .
A cell mechanism named anoikis has also been indicated as an important process during epithelial tube formation, as seen in mammary gland morphogenesis (Debnath et al. 2002; Mailleux et al. 2007 ). This is based on the loss of cell anchorage, which disturbs cell-cell and cell-extracellular matrix adhesion interactions, playing important role in the physiologic induction of apoptosis during development and pathogenesis, mainly regarding metastatic transformation (Grossmann 2002) . Corroborating this hypothesis, in our SG explant cultures, the apoptotic inhibition marker FITC-Z-VAD-FMK indicated the presence of many unorganized cells remaining in the center of the presumptive duct, not showing a clear lumen space, and being detached from the polarized epithelial cells lining the cavity. Given that anoikis is also potentially responsible for triggering apoptosis during lumen space opening, cavitation could actually represent a special case of cord hollowing, which requires cell polarization and the extra step of clearing the lumen (Andrew and Ewald 2010) .
In conclusion, initial lumen formation in the SG main stalk seems to occur by an apoptosis-driven mechanism. The Figure 5. Inhibition of caspases at embryonic day 13.5 (E13.5) leads to loss of lumen formation in the main stalk. Explants cultured from E13.5 for 72 h, with or without Z-VAD-FMK inhibitor. FITC-Z-VAD-FMK added to all cultures prior to fixation to label cells that are currently undergoing apoptosis (control and treated groups; A′-F′) and caspase positive cells that have been inhibited from undergoing apoptosis (treated group) (B′, D′, F′). (A, C, E) Morphologic images of control explants (DMSO treated). Arrowheads indicate areas of branching morphogenesis. (A′, C′, E′) Confocal images of the same control group highlighting absence of apoptosis at this stage inside the main ducts (arrows) when treated with FITC-Z-VAD-FMK before fixation. (E) Some apoptosis (green label) is evident in the mesenchyme at high levels of DMSO. (B, D, F) Pan-caspase inhibition at a range of concentrations, demonstrating defects in branching morphogenesis (arrowheads) and expansion of the duct diameter (arrows) in the absence of caspases. (B′, D′, F′) Confocal images of the same treated group highlighting presence of cells that were inhibited from undergoing apoptosis (green-labeled cells) inside the main ducts (arrows). The main ducts are filled with cells rather than having a cell-free lumen, as seen in controls. High levels of apoptosis (green label) are observed in the mesenchyme. Scale bar = 500 µm. This figure is available in color online at http://jdr.sagepub.com.
decreasing expression of apoptotic cells through SG development either in ducts or acini suggests that further lumen formation and maintenance of the subsequent ducts possibly use other mechanisms. Cell polarization, anoikis, and nonapoptotic cell death pathways may be essential to these developmental processes. It will therefore be important to further explore these ideas to establish a definite causal relationship among lumen formation, lumen maintenance, and cell death.
